| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
195,811,000 |
| Market
Cap: |
1.32(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.08 - $6.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
155,000 |
191,958 |
| Total Buy Value |
$0 |
$0 |
$579,644 |
$685,344 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
1,500,000 |
1,500,000 |
4,083,538 |
4,083,538 |
| Total Sell Value |
$9,143,159 |
$9,143,159 |
$19,811,348 |
$19,811,348 |
| Total People Sold |
1 |
1 |
4 |
4 |
| Total Sell Transactions |
5 |
5 |
11 |
11 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Grossman Adam S |
President & CEO |
• • – |
2014-05-14 |
4 |
B |
$7.50 |
$3,750 |
D/D |
500 |
584,457 |
2.73 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2014-05-14 |
4 |
B |
$7.51 |
$22,530 |
I/I |
3,000 |
583,957 |
2.58 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2013-12-10 |
4/A |
B |
$7.30 |
$3,650 |
I/I |
500 |
575,574 |
2.1 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2013-12-10 |
4 |
B |
$7.30 |
$26,645 |
I/I |
3,650 |
578,724 |
2.1 |
- |
|
| Lenz Brian |
Chief Financial Officer |
• – – |
2013-10-22 |
4 |
B |
$8.50 |
$8,500 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| Elms Steve |
10% Owner |
– – • |
2013-10-22 |
4 |
B |
$8.50 |
$3,500,003 |
I/I |
411,765 |
3,620,143 |
1.5 |
- |
|
| Guiheen Lawrence P. |
Director |
– • – |
2013-10-22 |
4 |
B |
$8.50 |
$42,500 |
D/D |
5,000 |
5,000 |
2.39 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2013-10-22 |
4 |
B |
$8.50 |
$574,991 |
I/I |
67,646 |
575,074 |
2.1 |
- |
|
| Grossman Jerrold B |
Director |
– • – |
2013-10-22 |
4 |
B |
$8.50 |
$99,994 |
D/D |
11,764 |
507,428 |
2.39 |
- |
|
| Grossman Adam S |
President & CEO |
• • – |
2013-10-22 |
4 |
B |
$8.50 |
$199,997 |
I/I |
23,529 |
580,957 |
2.66 |
- |
|
| Burrill & Co (bcf Iv Gp), Llc |
10% Owner |
– – • |
2013-10-22 |
4 |
B |
$8.50 |
$2,625,004 |
I/I |
308,824 |
1,433,304 |
1.5 |
- |
|
| Purcell Dennis J |
10% Owner |
– – • |
2012-02-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,516,855 |
|
- |
|
| Wetherell David S |
Director |
– • • |
2012-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
885,417 |
885,417 |
|
- |
|
| Grossman Adam S |
President & CEO |
• • • |
2012-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
438,919 |
438,919 |
|
- |
|
| Grossman Jerrold B |
Director |
– • – |
2012-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
390,286 |
390,286 |
|
- |
|
| Elms Steve |
Director |
– • – |
2012-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,516,855 |
2,516,855 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2012-02-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,516,855 |
2,516,855 |
|
- |
|
| R & R Investments Vi Llc |
10% Owner |
– – • |
2012-02-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,960,660) |
39,340 |
|
- |
|
| Kling Arnold P |
President |
• • • |
2012-02-13 |
4 |
D |
$0.00 |
$0 |
D/D |
(391,515) |
8,485 |
|
- |
|
| Warshaw Kirk M |
CFO, SecretaryOfficer |
• – – |
2006-09-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
- |
|
| R & R Investments Vi Llc |
10% Owner |
– – • |
2006-09-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,000,000 |
|
- |
|
| Kling Arnold P |
PresidentOfficer |
• • • |
2006-09-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
400,000 |
|
- |
|
222 Records found
|
|
Page 9 of 9 |
|
|
0.07 (1.05%) 
